KyungMann Kim

Celecoxib for the Prevention of Sporadic Colorectal Adenomas

Monica M. Bertagnolli, Craig Eagle, Ann G. Zauber et al. · New England Journal of Medicine · 2006 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

Sandra J. Horning, Edie Weller, KyungMann Kim et al. · Journal of Clinical Oncology · 2004 · 352 citations

Medicine, Oncology, Radiation Oncology +14

Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy

David Delgado, Jacquelyn A. Hank, Jill Kolesar et al. · Cancer Research · 2010 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma

Fariba Navid, Paul M. Sondel, Raymond Barfield et al. · Journal of Clinical Oncology · 2014 · 164 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

David M. King, Mark R. Albertini, Heidi Schalch et al. · Journal of Clinical Oncology · 2004 · 146 citations · Full text

Medicine, Oncology, Pharmacology +17